Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ 7GsKD=bl]
sV
a0eGc
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© S
\]O8#OX
/"?DOsJ.
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© A5yVxSF
d'ZNp2L
1.Co-stimulators (or co-stimulating molecules)
F/5G~17
ylZQwICk
2.NK-kB "UMaZgI
n>y,{"J{
3.Immunoglobulin superfamily b+|Jw\k
MZ,1 mR
4.antigen-presenting cell (APC) y ;[~(Yg[
tjx8UgSi
5.death domain k9rws
JK =A=
6.CCR and CXCR
JFm@jc
z.cDb
kf}
7.Lectin (or mitogen) NLMvi!5w,
n]IF`kYQV
8.Clusters of differentiation, CD) Z?'CS|ud
4<#ItQ(
9.B7 family b}R_@_<u
1z6aMd6.
10.Cytotoxic T lymphocyte, CTL) 7_1 Iadb
Ea@0>_U|
11.IL-15 and IL-15 receptor (IL-15R) _C/|<Ot:
'\#q7YjaL
12.MHC restriction YP02/*'
#Zm`*s`
13.Affinity-chromatography ; CCg]hX
F6q=W#~
14.Cyctosprin A, CsA ':4<[Vk
lKejWT`;
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) utZI'5i
V|'@D#\
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© l ubsL I
ElW\;C:K*
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 e` 4mrBtz|
1yE',9?
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ #'&-S@/nQs
w
PR Ns9^
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 F-3=eKZ
5_!L"sJ
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© -KGJr
~%*l>GkP*
ÃâÒßѧרҵ£º "Q
OQ
K` N$nOw
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ "Y+VNS
QgU]3`z"
Ïû»¯ÄÚ¿Æ£º 4xW~@meNB
%.$!VTO"
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ (>0`e8v!
z#Jw?K_
ѪҺ²¡Ñ§×¨Òµ£º F[\T'{
U[pHT _U
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿